#Hepatology Archives

Immune Dysfunction and Infection Risk in Advanced Liver Disease

By Mourabit Halima 2025.02.17

The latest review in Gastroenterology explores the complex relationship between immune dysfunction and infection risk in advanced liver disease, highlighting the contributions of Brett McGettigan, Maria Hernandez-Tejero, Harmeet Malhi, and…

Advancing Liver Cancer Care: Join the EASL Liver Cancer Summit 2025 in Paris

By Mourabit Halima 2025.02.17

The EASL Liver Cancer Summit 2025 will take place in Paris from February 20-22, bringing together leading experts to discuss the latest developments in liver cancer diagnosis, prognosis, and treatment.…

Expert Interview with Dr. Jiajie Liao: Optimizing Cost-Effective Strategies for Hepatitis B Treatment

By Mourabit Halima 2025.01.06

Recently, the American Association for the Study of Liver Diseases (AASLD 2024) was held in San Diego, USA. The prestigious event brought together leading experts and scholars in the field…

AASLD 2024: Dr. Mingqin Lu’s Team Presents Study on Biomimetic Exosomes Loaded with Iridium Nanozyme for Acute Liver Failure Treatment

By Mourabit Halima 2024.12.17

At the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, Professor Mingqin Lu’s team from The First Affiliated Hospital of Wenzhou Medical University unveiled their latest…

AASLD 2024丨Dr. Jun Chen: Advances in Diagnosis and Prognosis of MAFLD

By Lisa Cui 2024.12.10

At the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), metabolic-associated fatty liver disease (MAFLD) garnered significant attention. Dr. Jun Chen from Shenzhen Third People’s…

AASLD Featured New Voices | Terry Yip and Jimmy Lai Explore the New Progress of Liver Disease

By Mourabit Halima 2024.12.05

Editor's note: At the recent AASLD 2024, the annual meeting of the American Association for the Study of Liver Diseases, top experts from the global liver disease field gathered to…

AASLD 2024丨Weight-Loss Surgery vs. Medication: A 5-Year Mortality Comparison in MAFLD Patients

By Peng Longmei 2024.12.04

The rising mortality rate among patients with metabolic dysfunction-associated fatty liver disease (MAFLD) underscores the need for effective interventions. At the 2024 AASLD Annual Meeting, Dr. Leith Ghani from the…

AASLD 2024丨Dr. Qing Xie’s Team: TMF Improves Efficacy and Safety in ALT-Normal Chronic HBV Patients—Midterm Results from the PROMOTE Study

By Mourabit Halima 2024.12.04

At the 2024 AASLD Annual Meeting, Dr. Qing Xie's team from Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, presented findings on the efficacy and safety of a novel…

AASLD 2024丨Artificial Intelligence Enhancing Early Diagnosis of Metabolic Associated Steatotic Liver Disease

By Mourabit Halima 2024.11.21

At the 2024 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) held on November 15 in San Diego, California, a groundbreaking study highlighted the transformative…

Chinese Expertise at AASLD 2024: Dr. Huiguo Ding’s Team Advances Non-Invasive Differentiation of PSVD and Cirrhotic Portal Hypertension Using Machine

By Mourabit Halima 2024.11.21

From November 15–19, 2024, the American Association for the Study of Liver Diseases (AASLD) convened in San Diego, USA. A study led by Dr. Huiguo Ding’s team from the Beijing…